712
Participants
Start Date
May 29, 2017
Primary Completion Date
April 18, 2025
Study Completion Date
April 18, 2025
Pemetrexed
Patients will be administered pemetrexed chemotherapy as per protocol with either cisplatin or carboplatin
Paclitaxel
Patients will be administered paclitaxel chemotherapy as per protocol with either cisplatin or carboplatin
Gemcitabine
Patients will be administered gemcitabine chemotherapy as per protocol with either cisplatin or carboplatin
Cisplatin
Administered with either Pemetrexed, Paclitaxel or gemcitabine.
Carboplatin
Administered with either Pemetrexed, Paclitaxel or gemcitabine.
cemiplimab
Patients will be administered cemiplimab as per protocol.
Clinical Study Site, Albury
Clinical Study Site, Wollongong
Clinical Study Site, Fitzroy
Clinical Study Site, Minsk
Clinical Study Site, Mogilev
Clinical Study Site 1, Porto Alegre
Clinical Study Site, Barretos
Clinical Study Site, Curitiba
Clinical Study Site, Joinville
Clinical Study Site, Lajeado
Clinical Study Site, Mogi das Cruzes
Clinical Study Site, Passo Fundo
Clinical Study Site, Pelotas
Clinical Study Site 2, Porto Alegre
Clinical Study Site 3, Porto Alegre
Clinical Study Site, Recife
Clinical Study Site, Rio de Janeiro
Clinical Study Site, Salvador
Clinical Study Site, Santa Cecília
Clinical Study Site, São José do Rio Preto
Clinical Study Site #3, São Paulo
Clinical Study Site #4, São Paulo
Clinical Study Site 1, São Paulo
Clinical Study Site 2, São Paulo
Clinical Study Site, Dobrich
Clinical Study Site, Gabrovo
Clinical Study Site, Recoleta
Clinical Study Site, Santiago
Clinical Study Site, Temuco
Clincial Study Site, Viña del Mar
Clinical Study Site, Lanshan
Clinical Study Site, Guangdong
Clinical Study Site, Harbin
Clinical Study Site, Linyi
Clinical Study Site 1, Shanghai
Clinical Study Site 2, Shanghai
Clinical Study Site 1, Tianjin
Clinical Study Site 2, Tianjin
Clinical Study Site, Xuzhou
Clinical Study Site, Zhejiang
Clinical Study Site, Barranquilla
Clinical Study Site, Bogotá
Clinical Study Site, Floridablanca
Clinical Study Site, Nový Jičín
Clinical Study Site, Pelhřimov
Clinical Study Site, Prague
Clinical Study Site, Batumi
Clinical Study Site #6, Tbilisi
Clinical Study Site 1, Tbilisi
Clinical Study Site 2, Tbilisi
Clinical Study Site 3, Tbilisi
Clinical Study Site 4, Tbilisi
Clinical Study Site 5, Tbilisi
Clinical Study Site, Pátrai
Clinical Study Site, Cholargós
Clinical Study Site 1, Athens
Clinical Study Site 2, Athens
Clinical Study Site 3, Athens
Clinical Study Site, Larissa
Clinical Study Site, Pylaia
Clinical Study Site 1, Thessaloniki
Clinical Study Site 2, Thessaloniki
Clinical Study Site 3, Thessaloniki
Clinical Study Site, Gyula
Clinical Study Site, Tatabánya
Clinical Study Site, Farkasgyepű
Clinical Study Site, Budapest
Clinical Study Site, Debrecen
Clinical Study Site, Zalaegerszeg
Clinical Study Site, Amman
Clinical Study Site, Irbid
Clinical Study Site, Bsalîm
Clinical Study Site, Mazraat ech Choûf
Clinical Study Site, Sidon
Clinical Study Site, Kampung Baharu Nilai
Clinical Study Site #1, Kuala Lumpur
Clinical Study Site #2, Kuala Lumpur
Clinical Study Site, Kuching
Clinical Study Site, Pulau Pinang
Clinical Study Site, Tanjong Bungah
Clinical Study Site, Coahuila
Clinical Study Site, Cuautitlán
Clinical Study Site, Jalisco
Clinical Study Site, León
Clinical Study Site 1, Monterrey
Clinical Study Site 2, Monterrey
Clinical Study Site 3, Monterrey
Clinical Study Site, Oaxaca City
Clinical Study Site, San Luis Potosí City
Clinical Study Site, Bacolod City
Clinical Study Site, Batangas
Clinical Study Site, Cebu
Clinical Study Site, City of Taguig
Clinical Study Site, Davao City
Clinical Study Site 1, Manila
Clinical Study Site 2, Manila
Clinical Study Site #1, Quezon City
Clinical Study Site #2, Quezon City
Clinical Study Site, Dąbrowa Górnicza
Clinical Study Site, Gdynia
Clinical Study Site, Krakow
Clinical Study Site, Lodz
Clinical Study Site, Olsztyn
Clinical Study Site, Poznan
Clinical Study Site, Prabuty
Clinical Study Site, Radom
Clinical Study Site, Rzeszów
Clinical Study Site, Torun
Clinical Study Site, Warsaw
Clinical Study Site, Wodzisław Śląski
Clinical Study Site 1, Craiova
Clinical Study Site 2, Craiova
Clinical Study Site, Floreşti
Clinical Study Site, Ploieşti
Clinical Study Site, Timișoara
Clinical Study Site, Ufa
Clinical Study Site, Pushkin
Clinical Study Site, Arkhangelsk
Clinical Study Site, Belgorod
Clinical Study Site, Chelyabinsk
Clinical Study Site, Kaluga
Clinical Study Site, Kazan'
Clinical Study Site, Kemerovo
Clinical Study Site, Kislino
Clinical Study Site, Kursk
Clinical Study Site 1, Moscow
Clinical Study Site 2, Moscow
Clinical Study Site 3, Moscow
Clinical Study Site, Omsk
Clinical Study Site, Pyatigorsk
Clinical Study Site 1, Saint Petersburg
Clinical Study Site 2, Saint Petersburg
Clinical Study Site 3, Saint Petersburg
Clinical Study Site 4, Saint Petersburg
Clinical Study Site, Samara
Clinical Study Site, Saransk
Clinical Study Site, Sochi
Clinical Study Site 1, Tomsk
Clinical Study Site 2, Tomsk
Clinical Study Site, Yekaterinburg
Clinical Study Site, Manresa
Clinical Study Site, Barcelona
Clinical Study Site, Pamplona
Clinical Study Site, Chang-hua
Clinical Study Site, Hualien City
Clinical Study Site 1, Kaohsiung City
Clinical Study Site 2, Kaohsiung City
Clinical Study Site 1, New Taipei City
Clinical Study Site 2, New Taipei City
Clinical Study Site 1, Taichung
Clinical Study Site 2, Taichung
Clinical Study Site 1, Taipei
Clinical Study Site 2, Taipei
Clinical Study Site 3, Taipei
Clinical Study Site, Hat Yai
Clinical Study Site, Lopburi
Clinical Study Site #1, Bangkok
Clinical Study Site #2, Bangkok
Clinical Study Site, Chiang Rai
Clinical Study Site, Khon Kaen
Clinical Study Site, Lampang
Clinical Study Site, Phitsanulok
Clinical Study Site, Ratchathewi
Clinical Study Site, Udon Thani
Clinical Study Site 1, Adana
Clinical Study Site 2, Adana
Clinical Study Site 1, Ankara
Clinical Study Site 2, Ankara
Clinical Study Site 3, Ankara
Clinical Study Site 4, Ankara
Clinical Study Site 5, Ankara
Clinical Study Site, Edirne
Clinical Study Site 1, Istanbul
Clinical Study Site 2, Istanbul
Clinical Study Site 3, Istanbul
Clinical Study Site 4, Istanbul
Clinical Study Site 1, Izmir
Clinical Study Site 2, Izmir
Clinical Study Site 3, Izmir
Clinical Study Site, Samsun
Clinical Study Site, Dnipro
Clinical Study Site, Ivano-Frankivsk
Clinical Study Site, Kharkiv
Clinical Study Site, Kherson
Clinical Study Site 1, Kiev
Clinical Study Site 2, Kiev
Clinical Study Site, Kirovohrad
Clinical Study Site 1, Kyiv
Clinical Study Site 2, Kyiv
Clinical Study Site, Uzhhorod
Clinical Study Site, Vinnytsia
Clinical Study Site, Zaporizhzhya
Collaborators (1)
Sanofi
INDUSTRY
Regeneron Pharmaceuticals
INDUSTRY